Yantai Dongcheng Bio(002675.SZ) subsidiary, Lanna Cheng, has obtained the license for production of radioactive pharmaceuticals.
Dongcheng Pharmaceuticals (002675.SZ) announced that its controlling subsidiary, Yantai Lanna Cheng Biotechnology Co., Ltd. ("Lannacheng"), has recently received a notification that it has obtained a "Radiopharmaceutical Production License" issued by the Shandong Provincial Drug Administration. This acquisition of a "Drug Production License" by Lannacheng is expected to have no significant impact on the company's current performance. The commercial production of Fluorine [18F] Sorapide Injection can proceed after obtaining the drug's marketing approval number.
Yantai Dongcheng Biochemicals (002675.SZ) announced that recently, the company received a notification from its controlling subsidiary Yantai Lannacheng Biotechnology Co., Ltd. ("Lannacheng") that it has obtained a "Radiopharmaceutical Production License" issued by the Shandong Provincial Drug Administration. The acquisition of the "Drug Production License" by Lannacheng is expected to have no significant impact on the company's current performance. The commercial production of Fluoride [18F] sirtopeptide injection can proceed after obtaining the drug marketing approval number.
Related Articles
KWG GROUP(01813): Request for liquidation hearing postponed to December 8th.
On December 2nd, PRU (02378) spent 2.9929 million pounds repurchasing 272,000 shares.
WEIGAO GROUP (01066) spent HK$658,400 to repurchase 120,000 shares on December 3rd.
KWG GROUP(01813): Request for liquidation hearing postponed to December 8th.
On December 2nd, PRU (02378) spent 2.9929 million pounds repurchasing 272,000 shares.
WEIGAO GROUP (01066) spent HK$658,400 to repurchase 120,000 shares on December 3rd.
